Bruker Reports Fourth Quarter and Full Year 2023 Financial Results

Q4 2023 revenues of $854.5 million, up 20.6% year-over-year ; organic revenue up 15.9% yoy



Q4 2023 GAAP EPS of $1.41, including a $0.99 per share gain on PhenomeX acquisition[1];



Q4 2023...

Related Keywords

Taiwan ,Israel ,Ukraine ,China ,United States ,Russia ,Bruker Nano ,Frank Laukien ,Bruker Biospin ,Asia Pacific ,Securities Exchange ,Bruker Corporation Nasdaq ,Exchange Commission ,Bruker Corporation ,Bruker Energy Supercon Technologies ,Phenomex Inc ,Scientific Instruments ,Supercon Technologies ,Eastern Standard ,Investor Relations ,Fourth Quarter ,Securities Act ,Securities Exchange Act ,Purchase Agreement ,Before Tax ,Per Share ,Cash Flow ,Invested Capital ,Tax Provision ,Revenue Growth ,Organic Revenue ,Organic Revenue Growth ,Bruker Scientific Instruments ,Nano Segments ,Markets ,